Abstract
In the new era of medicine, 3D printing technique in pharmaceutical manufacturing has already yielded success. For example, Aprecia®, an FDA-approved pharmaceutical company, has launched its first approved product which is not only unique because of a novel manufacturing process but also better than conventional compressed tablets. 3D printing is an inexpensive additive manufacturing technique that builds a 3D object by successive layering on top of each other in a 2D fashion. The layering of the object in process is controlled digitally in a computer-aided design (CAD). 3D printing of pharmaceuticals suits best for personalised therapy, not only in case of doses but dosage form as well. A personalised dosage form can be designed and printed in such a way that the drugs are combined in a single pill (polypill). This cannot only make the therapy and schedule convenient for patient but also increase adherence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Melchels FPW, Feijen J, Grijpma DW (2010) A review on stereolithography and its applications in biomedical engineering. Biomaterials 31(24):6121–6130
Khaled SA et al (2015) 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release 217:308–314
Garber AJ et al (2003) Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab 88(8):3598–3604
Murphy SV, Atala A (2014) 3D bioprinting of tissues and organs. Nat Biotechnol 32(8):773–785
CSC Leading Edge Forum (2012) 3D printing and the future of manufacturing. FALL. 36.
Deckard CR (1989) Method and apparatus for producing parts by selective sintering. Google Patents.
Crump SS (1992) Apparatus and method for creating three-dimensional objects. Google Patents.
Hull CW et al. (1994) Method and apparatus for production of high resolution three-dimensional objects by stereolithography. Google Patents.
Verma A, Rai R (2013) Energy efficient modeling and optimization of additive manufacturing processes. In solid freeform fabrication symposium, Austin, TX.
Leong KF et al (2001) Fabrication of porous polymeric matrix drug delivery devices using the selective laser sintering technique. Proc Inst Mech Eng H 215(2):191–201
Jacob J (2014) et al. Rapid disperse dosage form containing levetiracetam. Google Patents.
Katstra WE et al (2000) Oral dosage forms fabricated by three dimensional printing. J Control Release 66(1):1–9
Rowe CW et al (2000) Multimechanism oral dosage forms fabricated by three dimensional printing. J Control Release 66(1):11–17
Chia HN, Wu BM (2015) Recent advances in 3D printing of biomaterials. J Biol Eng 9:4
Khaled SA et al (2014) Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm 461(1–2):105–111
Skowyra J, Pietrzak K, Alhnan MA (2015) Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci 68:11–17
Pietrzak K, Isreb A, Alhnan MA (2015) A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm 96:380–387
Melocchi A et al (2015) 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J Drug Deliv Sci Technol 30(Part B):360–367
Wang J et al (2016) Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm 503(1–2):207–212
Wang C-C et al (2006) Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology. Drug Dev Ind Pharm 32(3):367–376
Huang W et al (2007) Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int J Pharm 339(1–2):33–38
Yu DG et al (2009) Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int J Pharm 370(1–2):160–166
Yu DG et al (2009) Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by three-dimensional printing. J Pharm Pharmacol 61(3):323–329
Wu BM et al (1996) Solid free-form fabrication of drug delivery devices. J Control Release 40(1–2):77–87
Khaled SA et al (2015) 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm 494(2):643–650
Goyanes A et al (2015) 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharm 12(11):4077–4084
Goyanes A et al (2015) Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm 496(2):414–420
Goyanes A et al (2014) Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm 476(1–2):88–92
Goyanes A et al (2015) 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm 89:157–162
Goyanes A et al (2015) Effect of geometry on drug release from 3D printed tablets. Int J Pharm 494(2):657–663
Water JJ et al (2015) Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J Pharm Sci 104(3):1099–1107
Weisman JA et al (2015) Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applications. Int J Nanomedicine 10:357–370
Sun Y, Soh S (2015) Printing tablets with fully customizable release profiles for personalized medicine. Adv Mater 27(47):7847–7853
Alhijjaj M, Belton P, Qi S (2016) An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur J Pharm Biopharm 108:111–125
Okwuosa TC et al (2016) A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm Res 33(11):2704–2712
Okwuosa TC et al (2017) Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-Centred therapy. Pharm Res 34(2):427–437
Sadia M et al (2016) Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int J Pharm 513(1–2):659–668
Zhang J et al (2017) Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm 519(1–2):186–197
Goyanes A et al (2017) Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int J Pharm 527(1–2):21–30
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Sadia, M., Alhnan, M.A., Ahmed, W., Jackson, M.J. (2018). 3D Printing of Pharmaceuticals. In: Jackson, M., Ahmed, W. (eds) Micro and Nanomanufacturing Volume II. Springer, Cham. https://doi.org/10.1007/978-3-319-67132-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-67132-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67130-7
Online ISBN: 978-3-319-67132-1
eBook Packages: EngineeringEngineering (R0)